Catalent
CTLT
#1488
Rank
A$18.33 B
Marketcap
$101.01
Share price
0.00%
Change (1 day)
17.78%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

EPS for Catalent (CTLT)

EPS in 2023 (TTM): -$1.94

According to Catalent's latest financial reports the company's current EPS (TTM) is -$2.05. In 2022 the company made an earnings per share (EPS) of $3.61 a decrease over its 2021 EPS that were of $5.20.

EPS history for Catalent from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.94-153.7%
2022$3.61-30.58%
2021$5.2079.67%
2020$2.90114.12%
2019$1.35-15%
2018$1.5975.44%
2017$0.91-22.97%
2016$1.18-59.56%
2015$2.91282.05%
2014$0.76-378.2%
2013-$0.27

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$1.26-161.24%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.19-41.86%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.24 9.30%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$10.17-595.35%๐Ÿ‡บ๐Ÿ‡ธ USA